Media headlines about Medical Transcription Billing (NASDAQ:MTBC) have been trending somewhat positive on Thursday, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Medical Transcription Billing earned a coverage optimism score of 0.22 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 46.6917203128533 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:
- Analysts See $-0.09 EPS for Medical Transcription Billing, Corp. (MTBC) on May, 9 (skatronixxx.com)
- EPS for Medical Transcription Billing, Corp. (MTBC) forecasted at $-0.09 (thecasualsmart.com)
- Jet-Setter Stocks: New Concept Energy, Inc. (NYSE:GBR), Medical Transcription Billing, Corp. (NASDAQ:MTBC) (thestreetpoint.com)
- Anticipated $-0.09 EPS for Medical Transcription Billing, Corp. (MTBC) on May, 9 (styleonfleek365.com)
- Medical Transcription Billing (MTBC) Stock Rating Lowered by ValuEngine (americanbankingnews.com)
MTBC stock traded up $0.02 during trading hours on Thursday, hitting $3.50. The company’s stock had a trading volume of 59,370 shares, compared to its average volume of 407,096. The company has a quick ratio of 2.06, a current ratio of 2.06 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $40.48, a price-to-earnings ratio of -26.92 and a beta of 1.73. Medical Transcription Billing has a 12 month low of $0.29 and a 12 month high of $5.44.
Medical Transcription Billing (NASDAQ:MTBC) last posted its earnings results on Wednesday, March 7th. The technology company reported $0.04 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.01) by $0.05. Medical Transcription Billing had a negative net margin of 17.50% and a negative return on equity of 10.97%. The company had revenue of $8.29 million during the quarter, compared to the consensus estimate of $8.30 million. research analysts expect that Medical Transcription Billing will post -0.25 EPS for the current fiscal year.
A number of research analysts recently commented on the stock. ValuEngine raised shares of Medical Transcription Billing from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th. HC Wainwright began coverage on shares of Medical Transcription Billing in a research report on Friday, March 2nd. They set a “buy” rating on the stock. Finally, Zacks Investment Research downgraded shares of Medical Transcription Billing from a “buy” rating to a “hold” rating in a research report on Saturday, January 6th.
In other news, CEO Stephen Andrew Snyder sold 5,450 shares of the business’s stock in a transaction on Monday, March 26th. The shares were sold at an average price of $25.36, for a total value of $138,212.00. Following the completion of the sale, the chief executive officer now directly owns 2,800 shares in the company, valued at $71,008. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Mahmud Ul Haq sold 6,000 shares of the business’s stock in a transaction on Monday, March 26th. The stock was sold at an average price of $25.36, for a total transaction of $152,160.00. Following the completion of the sale, the chairman now owns 3,000 shares of the company’s stock, valued at $76,080. The disclosure for this sale can be found here. 49.70% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: This story was first published by Zolmax and is the property of of Zolmax. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://zolmax.com/investing/medical-transcription-billing-mtbc-given-coverage-optimism-rating-of-0-22/2118695.html.
About Medical Transcription Billing
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.